Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene

Gastroenterology

Volumn 125, Issue 4, 2003, Pages 1164-1174

  Boushey, Robin P ^a   Abadir, Amir ^a   Flamez, Daisy ^b   Baggio, Laurie L ^a   Li, Yazhou ^a   Berger, Veerle ^b   Marshall, Bess A ^c   Finegood, Diane ^f   Wang, Timothy C ^d   Schuit, Frans ^b   Drucker, Daniel J ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; GASTRIN; GLUCAGON; INSULIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENE TARGETING; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; HORMONE RESPONSE; HYPOGLYCEMIA; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS PERFUSION; PRIORITY JOURNAL;

EID: 0141483035     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)01195-8     Document Type: Article

References (43)

1. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918-1929.
2. Iwase K, Evers BM, Hellmich MR, Guo YS, Higashide S, Kim HJ, Townsend CM Jr. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997; 113:782-790.
3. Dockray GJ, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001;63:119-139.
4. Shulkes A, Baldwin GS. Biology of gut cholecystokinin and gastrin receptors. Clin Exp Pharmacol Physiol 1997;24:209-216.
5. Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray GJ, Wang TC. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997;113:1015-1025.
6. Friis-Hansen L, Sundler F, Li Y, Gillespie PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF, Samuelson LC. Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol 1998;274:G561-G568.
7. Cobb S, Wood T, Tessarollo L, Velasco M, Given R, Varro A, Tarasova N, Singh P. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice. Gastroenterology 2002;123:516-530.
8. Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinborn M, Kopin AS. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997;112:280-286.
9. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K, Matsui T, Noda T. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci U S A 1996;93:11825-11830.
10. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999;103:1119-1126.
11. Brand SJ, Fuller PJ. Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 1988;263:5341-5347.
12. Furukawa M, Magami Y, Azuma T, Inokuchi H, Nakayama D, Moriyasu F, Kawai K, Hattori T. Proliferation and functional changes of pancreatic gastrin cells in neonatal rat. Pancreas 2001;23:421-426.
13. Saillan-Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, Guy-Crotte O, Escrieut C, Vaysse N, Gomis R, Tarasova N, Fourmy D. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 1999;48:2015-2021.
14. Wang TC, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino GT, Schmidt EV, Brand SJ. Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest 1993;92:1349-1356.
15. Yen TW, Sandgren EP, Liggitt HD, Palmiter RD, Zhou W, Hinds TR, Grippo PJ, McDonald JM, Robinson LM, Bell RH Jr. The gastrin receptor promotes pancreatic growth in transgenic mice. Pancreas 2002;24:121-129.
16. Clerc P, Leung-Theung-Long S, Wang TC, Dockray GJ, Bouisson M, Delisle MB, Vaysse N, Pradayrol L, Fourmy D, Dufresne M. Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology 2002;122:428-437.
17. Rooman I, Lardon J, Flamez D, Schuit F, Bouwens L. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology 2001;121:940-949.
18. Rooman I, Lardon J, Bouwens L. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 2002; 51:686-690.
19. Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y. Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 2002;91:414-420.
20. Bjorkqvist M, Norlen P, Kitano M, Chen D, Zhao CM, de la Cour CD, Gagnemo-Persson C, Hakanson R. Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats. Pharmacol Toxicol 2001;89:208-213.
21. Wang TC, Dockray GJ. Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice. Am J Physiol 1999;277:G6-G11.
22. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F, Bonner-Weir S, Kanarek R, Beinborn M. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 1999; 103:383-391.
23. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide receptor gene. Nat Med 1996;2:1254-1258.
24. Baggio L, Adatia F, Bock T, Brubaker PL, Drucker DJ. Sustained expression of exendin-4 does not perturb glucose homeostasis β cell mass or food intake in metallothionein-preproexendin transgenic mice. J Biol Chem 2000;275:34471-34477.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
26. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 1987;84:3434-3438.
27. Wang W, Hansen PA, Marshall BA, Holloszy JO, Mueckler MM. Insulin unmasks a C-terminal GLUT4 epitope and increases glucose transport across T-tubules in skeletal muscle. J Cell Biol 1996;135:1-16.
28. Flamez D, Van Breuseghem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F. Mouse pancreatic beta cells exhibit preserved glucose competence after disruption of the glucagon-like peptide 1 receptor gene. Diabetes 1998;47:646-652.
29. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001;50:1021-1029.
30. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 2003;278:471-478.
31. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology 1985;117:806-816.
32. Schuit FC, Pipeleers DG. Differences in adrenergic recognition by pancreatic A and B cells. Science 1986;232:875-877.
33. Schuit FC, Derde MP, Pipeleers DG. Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 1989;32:207-212.
34. Gerich JE. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus. Diabetes 1988;37:1608-1617.
35. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001;50:1-11.
36. Kaestner KH, Katz J, Liu Y, Drucker DJ, Schutz G. Inactivation of the winged helix transcription factor HNF3α affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev 1999;13:495-504.
37. Miki T, Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y, Horiuchi M, Ashcroft F, Minokoshi Y, Roeper J, Seino S. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001;4:507-512.
38. Bani Sacchi T, Bani D, Biliotti G. Nesidioblastosis and islet cell changes related to endogenous hypergastrinemia. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:261-276.
39. Verspohl EJ, Ammon HP, Williams JA, Goldfine ID. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 1986;35:38-43.
40. Fletcher DJ, Rowley WH, Pabst SJ, Brinn JE. Age-dependent stimulation of neonatal insulin release and inositol phosphate accumulation by CCK-8 and carbachol. Diabetes 1989;38:1337-1342.
41. Shimizu K, Kato Y, Shiratori K, Ding Y, Song Y, Furlanetto R, Chang TM, Watanabe S, Hayashi N, Kobayashi M, Chey WY. Evidence for the existence of CCK-producing cells in rat pancreatic islets. Endocrinology 1998;139:389-396.
42. Lacourse KA, Swanberg LJ, Gillespie PJ, Rehfeld JF, Saunders TL, Samuelson LC. Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am J Physiol 1999;276:G1302-G1309.
43. Zhu M, Noma Y, Mizuno A, Sano T, Shima K. Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima fatty rat: a model of spontaneous NIDDM. Diabetes 1996;45:941-946.